AUG 11, 2026 · JOURNAL ARTICLE
Optimal timing of recombinant growth hormone therapy in Prader-Willi syndrome: the case for very early initiation
Frontiers in Endocrinology
This is a narrative commentary synthesizing existing evidence to recommend early rhGH initiation in PWS, not reporting new primary data or a systematic review with meta-analysis.
Reported
Mean height gain with rhGH+1.67 SDS
BMI z-score reduction with rhGH−0.67 SDS
Fat mass proportion decrease with…−6.5% SDS